Search

everythinglearnresearchcommunity

for

Search:↓

A Miniature Pinscher dog with hair loss and scaling was diagnosed with pattern alopecia and improved with melatonin treatment.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Some supplements and hormones can increase hair loss by raising DHT levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Serum triglyceride levels are not linked to prostate cancer risk.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Finasteride doesn't affect hormone levels in normal men.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

High testosterone increases heart disease risk in women with PCOS.

DHT may increase the risk of heart disease and death in elderly men.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.